The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
mRNA Expression Signatures of Human Skeletal Muscle Atrophy Identify a Natural Compound that Increases Muscle Mass
Open accessAbstract
Skeletal muscle atrophy is a common and debilitating condition that lacks a pharmacologic therapy. To develop a potential therapy, we identified 63 mRNAs that were regulated by fasting in both human and mouse muscle, and 29 mRNAs that were regulated by both fasting and spinal cord injury in human muscle. We used these two unbiased mRNA expression signatures of muscle atrophy to query the Connectivity Map, which singled out ursolic acid as a compound whose signature was opposite to those of atrophy-inducing stresses. A natural compound enriched in apples, ursolic acid reduced muscle atrophy and stimulated muscle hypertrophy in mice. It did so by enhancing skeletal muscle insulin/IGF-I signaling and inhibiting atrophy-associated skeletal muscle mRNA expression. Importantly, ursolic acid's effects on muscle were accompanied by reductions in adiposity, fasting blood glucose, and plasma cholesterol and triglycerides. These findings identify a potential therapy for muscle atrophy and perhaps other metabolic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“UA appeared to mediate its effects through enhancement of insulin/IGF-I signaling and a reduction in the expression of the atrophy-associated genes MuRF1 and MAFbx [187]”
From New strategies in sport nutrition to increase exercise performance (2016) · cites this paper as [187]
In the citing paper
“Therefore, it is presently unclear whether UA supplementation in humans can reproduce the anti-atrophy or pro-hypertrophic data reported previously [187].”
From New strategies in sport nutrition to increase exercise performance (2016) · cites this paper as [187]
In the citing paper
“whilst 5 weeks of supplemented diet (0.27% UA) induced hypertrophy [187].”
From New strategies in sport nutrition to increase exercise performance (2016) · cites this paper as [187]
In the citing paper
“UA supplementation in mice (200 mg / kg via i.p. injection twice daily for 7 days) reduced muscle atrophy following denervation”
From New strategies in sport nutrition to increase exercise performance (2016) · cites this paper as [187]
In the citing paper
“Ursolic acid, a pentacyclic triterpenoid abundant in apples, reduces fasting- and denervation-induced muscle atrophy by inhibiting the mRNA expression of MAFbx and MuRF1 and induces skeletal muscle hypertrophy in SD rats [145].”
From Nutraceuticals in the Prevention and Treatment of the Muscle Atrophy (2021) · cites this paper as [145]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257 · cited 3×
“The connectivity score, represented on the y axis, is a measure of the strength of the correlation (Lamb et al., 2006). p < 0.004 for all compounds shown.”
InfluentialIdentification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521 · cited 3×
“Previous studies demonstrated that skeletal muscle atrophy is driven by conserved changes in skeletal muscle gene expression (Bodine et al., 2001a; Sandri et al., 2004).”
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012 · cited 2×
“Previous studies demonstrated that skeletal muscle atrophy is driven by conserved changes in skeletal muscle gene expression (Bodine et al., 2001a; Sandri et al., 2004).”
Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., et al. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1014 · Cited by 2,752 · cited 3×
“Previous studies demonstrated that skeletal muscle atrophy is driven by conserved changes in skeletal muscle gene expression (Bodine et al., 2001a; Sandri et al., 2004).”
Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964 · cited 3×
“We next examined whether ursolic acid might increase Akt activation in C2C12 skeletal myotubes, awell-established in vitro model of skeletal muscle (Sandri et al., 2004; Stitt et al., 2004).”
Pharmacology of oleanolic acid and ursolic acid
Liu, J. (1995) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(95)90032-2 · Cited by 1,431 · cited 1×
“Interestingly, because it exerts beneficial effects in animal models of diabetes and hyperlipidemia (Liu, 1995; Wang et al., 2009), ursolic acid is thought to be the active component in a variety of folkloric antidiabetic herbal medicines (Liu, 1995, 2005).”
Normal growth and development in the absence of hepatic insulin-like growth factor I
Yakar, S., Liu, J., STANNARD, B. S., Butler, A. A., Accili, D., Sauer, B., & LeRoith, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7324 · Cited by 1,418 · cited 1×
“We also measured the effect of ursolic acid on plasma IGF-I levels, which primarily reflect growth hormone-mediated hepatic IGF-I production (Yakar et al., 1999).”
Klaman, L. D., Boss, O., Peroni, O. D., Kim, J. K., Martino, J. L., Zabolotny, J. M., Moghal, N., Lubkin, M., Kim, Y.-B., Sharpe, A. H., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5479-5489.2000 · Cited by 1,235 · cited 1×
“However, neither global nor muscle-specific PTP1B knockout mice were found to possess increased muscle mass (Delibegovic et al., 2007; Klaman et al., 2000).”
Musarò, A., McCullagh, K., Paul, A., Houghton, L., Dobrowolny, G., Molinaro, M., Barton, E. R., L Sweeney, H., & Rosenthal, N. (2001) · Nature Genetics · doi:10.1038/84839 · Cited by 1,137 · cited 2×
“, 2005) and stimulatesmuscle hypertrophy (Barton-Davis et al., 1998; Musaro et al., 2001).”
Sandri, M., Lin, J., Handschin, C., Yang, W., Arany, Z. P., Lecker, S. H., Goldberg, A. L., & Spiegelman, B. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607795103 · Cited by 974 · cited 1×
“Of these, PGC-1a mRNA encodes a protein that inhibits atrophy-associated gene expression and skeletal muscle atrophy in mice (Sandri et al., 2006).”
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–344 of 344
Reconsidering phenotypic heart failure drug discovery
Toomey, J. R., & Upson, J. J. (2012) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2014.01.003
Gillbro, J. M., Merinville, E., Nilsson, M., Hagforsen, E., Moran, G., Al‐Bader, T., & Mavon, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-26594-0_146-1
The molecular pathogenesis of skeletal muscle atrophy
Bongers, K. S., Shibata, E. F., Snyder, P. M., Zabner, J., Moye-Rowley, S., Adams, C. M., & Henry, M. D. (2016) · doi:10.17077/etd.n2myp7k9
“01), similar to our previous reports [13, 25, 89].”
InfluentialNutritional interventions to preserve skeletal muscle mass
Backx, E. M. P. (2016) · doi:10.18174/389376
Bioinformatics Approaches to Biomarker and Drug Discovery in Aging and Disease
Fortney, K. (2012) · TSpace (University of Toronto)
Khudair, A.-R. N., & Shabaa, S. H. (2018) · Journal of University of Babylon for Pure and Applied Sciences · doi:10.29196/jub.v26i5.912
“200 Very good results of sciatic nerve regeneration obtained by using Ursolic Acid in this study are agreeing with what is found by [45] when they stated that Ursolic Acid can promote repair of peripheral nerves, can repair damaged neurons and promote neural regeneration after peripheral nerve injury.”
ResultRepurposing Clinic-Tested Drugs to Treat Rare Neurogenetic Diseases by Transcriptional Modulation
Hadwen, J. (2018) · uO Research (University of Ottawa) · doi:10.20381/ruor-21849
Orthogonal linear separation analysis: an approach to decompose the complex effects of a perturbagenPreprint
Mizuno, T., Kinoshita, S., Maedera, S., Ito, T., & Kusuhara, H. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/384446
“Many studies using CMap have succeeded in drug repositioning (Kosaka et al, 2013; Kunkel et al, 2011; Brum et al, 2015).”
BackgroundÁcido Ursólico y Composición Corporal
Vallejo-González, M., Monterrubio-Angulo, E., & Saldaña, R. G. (2018) · Educación y Salud Boletín Científico Instituto de Ciencias de la Salud Universidad Autónoma del Estado de Hidalgo · doi:10.29057/icsa.v7i13.3456
Understanding Disease and Disease Relationships Using Transcriptomic Data
Oerton, E. (2018) · Apollo (University of Cambridge) · doi:10.17863/cam.36391
Ácido ursólico pode ser eficaz na redução da adiposidade e aumento da massa muscular? Uma revisão
Lobo, P. C. B., Pimentel, G. D., & Mota, J. F. (2019) · Arquivos de Ciências do Esporte · doi:10.17648/aces.v6n4.3138
Pharmacological Intervention for Sarcopenia in Chronic Kidney Disease
Sakuma, K., & Yamaguchi, A. (2020) · Springer eBooks · doi:10.1007/978-981-15-2365-6_11
Liu, Q., Qiu, Y., & Xie, L. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.09.455708
Galli, D. (2008) · AMS Campus - AlmaDL
Gillbro, J. M., Merinville, E., Nilsson, M., Hagforsen, E., Moran, G., Al‐Bader, T., & Mavon, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-32383-1_146
Nutritional strategies to improve muscle quality during ageing
Grootswagers, P. (2020) · doi:10.18174/530397
Krendlinger, E. J., & Wolfmeier, U. H. (2022) · doi:10.1002/9783527807758.ch14
Wilk, E. J., Howton, T. C., Fisher, J. L., Oza, V. H., Brownlee, R. T., McPherson, K. C., Cleary, H. L., Yoder, B. K., George, J. F., Mrug, M. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.02.518863
Classification of Phytochemicals in Plants with Herbal Value
Abdelkhalek, S. T., Shi, J. H., Jin, M. X., Abdelgayed, S. S., & Wang, M. Q. (2024) · Reference series in phytochemistry · doi:10.1007/978-3-031-43199-9_12
Wang, Z., Luo, J., Jiang, L., Tang, C., Chen, Y., Yang, K., Wang, Z., Dong, J., Chen, X., Yin, Z., et al. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.109665
Miro, C., Iannuzzo, F., Acampora, L., Cicatiello, A. G., Sagliocchi, S., Schiano, E., Nappi, A., Restolfer, F., Stornaiuolo, M., Tenore, G. C., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115418
“Recent studies have highlighted its potential role in promoting neuronal regeneration following peripheral nerve injury (PNI), making it a promising candidate for therapeutic applications [8,10,21].”
InfluentialNisar, H., Prajapati, J., Mumtaz, A., Iftikhar, A., Faran, F., Mehmood, R. H., Shahid, S., & Goswami, D. (2025) · Integrative Biology · doi:10.1093/intbio/zyaf016
Upson, J. J., Schnackenberg, C. G., Lawhorn, B. G., Chen, Q., Sweet, D. T., Chendrimada, T. P., Brooks, C. A., Burgert, M. E., Louer, C. T., Zacco, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.24.678104
Veldman, J., Blanco, M. N. F., Kops, N., Koevoet, W. J. L. M., Bindels, E. M., van Beek, G., Hoogenboezem, R. M., Sivasubramaniyan, K., van Rooij, J., Lolli, A., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118773
Wilk, E. J., Howton, T. C., Fisher, J. L., Oza, V. H., Brownlee, R. T., McPherson, K. C., Cleary, H. L., Yoder, B. K., George, J. F., Mrug, M. M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26590916
Wilk, E. J., Howton, T. C., Fisher, J. L., Oza, V. H., Brownlee, R. T., McPherson, K. C., Cleary, H. L., Yoder, B. K., George, J. F., Mrug, M. M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26590913
Wilk, E. J., Howton, T. C., Fisher, J. L., Oza, V. H., Brownlee, R. T., McPherson, K. C., Cleary, H. L., Yoder, B. K., George, J. F., Mrug, M. M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26590910
Chen, M., Chen, H., Gu, Y., Sun, P., Sun, J., Yu, H., Zheng, H., & Chen, D. (2021) · Figshare · doi:10.6084/m9.figshare.15153998
Sun, J., Zhou, H., Chen, Z., Zhang, H., Cao, Y., Yao, X., Chen, X., Liu, B., Gao, Z., Shen, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24630475
Sun, J., Zhou, H., Chen, Z., Zhang, H., Cao, Y., Yao, X., Chen, X., Liu, B., Gao, Z., Shen, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24630340
Wilk, E. J., Howton, T. C., Fisher, J. L., Oza, V. H., Brownlee, R. T., McPherson, K. C., Cleary, H. L., Yoder, B. K., George, J. F., Mrug, M. M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26590919
Wilk, E. J., Howton, T. C., Fisher, J. L., Oza, V. H., Brownlee, R. T., McPherson, K. C., Cleary, H. L., Yoder, B. K., George, J. F., Mrug, M. M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26590922
Atypical protein kinase C activation drives intestinal glucose excretion in diabetes mellitus
Kang, C. W., Hong, Z.-Y., Oh, J. H., Farh, M. E.-A., Wang, E. K., Lee, S., Kang, U. H., Nam, J. H., Lee, Y. J., Shin, H., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69193-7
“This strategy has been applied successfully to cancer 36 , muscle atrophy 37 , acute myelogenous leukemia 38 , and Parkinson ’ s disease 39 .”
Nisha, N., Brenmoehl, J., Hoeflich, A., & Galow, A.-M. (2026) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2026.102113
Sadeghi, A., Alizade, S., Faramarzi, M., Rahimi, M., & Thapa, R. K. (2026) · Aging Medicine · doi:10.1002/agm2.70071
Savino, A., Liaci, C., Bertani, I., Rando, S., Camera, M., Merlo, G. R., Avalle, L., Poli, V., Kalebic, N., & Iorio, F. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.26.727809
“…gene expression signatures may have therapeutic potential (Arloth et al. 2015; Iorio et al. 2013; Lamb et al. 2006) (Dudley et al. 2011; Kunkel et al. 2011; Dönertaş et al. 2018; Wagner et al. 2015)(Arloth et al. 2015; Iorio et al. 2013; Lamb et al. 2006) Importantly, it has also been…”
Using Deep Learning Models of Gene Regulation to Guide Drug Prioritization
Huang, X., & Ovcharenko, I. (2026) · Pharmaceuticals · doi:10.3390/ph19071097
“…such as drug-induced or disease-associated transcriptional profiles, to identify compounds with opposing or corrective effects, and have yielded promising results across diverse disease contexts, such as muscle atrophy [10], neurodegenerative disorders [11,12], and infectious diseases [13].”
Lycopene Increases Skeletal Muscle Mass by Promoting Myoblast Differentiation
Wen, W., Ding, D., Pu, J., Zhang, Y., Luo, Y., Du, J., & Mou, D. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.72252
“The age-or disease-related loss of muscle functional impairment can be mitigated through nutritional interventions, which may due to increased muscle mass (Kunkel et al. 2011; Liu, Sun, et al. 2021; Liu, Yang, et al. 2021; Montesano et al. 2013).”
Lin, L., Chen, W., Mu, K., Xu, Y., He, J., Zheng, H., Tian, M., Xue, H., & Fang, T. (2026) · Food Research International · doi:10.1016/j.foodres.2026.120863
In Vivo Transcriptomics-Based Framework for Systematic Indication ExpansionPreprint
Palmer, Z., Koirala, S., Talukdar, N., Zhang, X., Garver, H. S., Mahlmeister, M., Huang, L., Joseph, D., Leshchiner, D. R., Shankar, R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.12.758524
He, Q., Tong, Y., Yu, Y., Ren, Z., Fang, D., Liu, Z., Li, H., Li, X., Zhu, Y., Cheng, J., et al. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6c04505
Becker, J., Ebert, B. E., Festel, G., & Blank, L. M. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1939566
Metadata
- Authors
- Kunkel, S. D., Suneja, M., Ebert, S. M., Bongers, K. S., Fox, D. K., Malmberg, S. E., Alipour, F., Shields, R. K., & Adams, C. M.
- Affiliations
- University of Iowa (US)
- Corresponding author
- Adams, Christopher M.
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 13
- Issue
- 6
- Pages
- 627-638
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC3120768
- OpenAlex
- W2099582158
- Cited by
- 345
- References
- 35
- Citations by year
- 2026: 15 · 2025: 17 · 2024: 18 · 2023: 22 · 2022: 23 · 2021: 36 · 2020: 24 · 2019: 35 · 2018: 26 · 2017: 24 · 2016: 25 · 2015: 27 · 2014: 16 · 2013: 19 · 2012: 16
- FWCI
- 6.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 777 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Diabetes Association (1R01AR059115-01)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- U.S. Department of Veterans Affairs
- Doris Duke Charitable Foundation
- Institute of Clinical and Translational Sciences
- National Institutes of Health (HL007121, T32 GM073610)
- University of Georgia Research Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- skeletal muscle atrophy, ursolic acid, muscle hypertrophy, fasting, spinal cord injury, mRNA expression signature, adiposity, metabolic disorders, natural compounds, apple
- MeSH terms
- Ursolic Acid, Animals, Cell Line, Fasting, Gene Expression Regulation, Hindlimb, Humans, Insulin, Insulin-Like Growth Factor I, Mice, Inbred C57BL, Muscle Denervation, Muscular Atrophy, Triterpenes, Signal Transduction, Gene Expression, Muscle, Skeletal, Muscle Fibers, Skeletal, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Mice, Muscle Strength
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
